van Soest H - Search Results

1

Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy.

Kok KF, van Soest H, van Herwaarden AE, van Oijen MG, Boland GJ, Halangk J, Berg T, de Vries RA, Drenth JP. Kok KF, et al. Among authors: van herwaarden ae, van soest h, van oijen mg. Eur J Gastroenterol Hepatol. 2010 Jul;22(7):808-12. doi: 10.1097/MEG.0b013e3283320113. Eur J Gastroenterol Hepatol. 2010. PMID: 19794310

2

No beneficial effects of amantadine in treatment of chronic hepatitis C patients.

van Soest H, van der Schaar PJ, Koek GH, de Vries RA, van Ooteghem NA, van Hoek B, Drenth JP, Vrolijk JM, Lieverse RJ, Houben P, van der Sluys Veer A, Siersema PD, Schipper ME, van Erpecum KJ, Boland GJ. van Soest H, et al. Among authors: van hoek b, van erpecum kj, van der schaar pj, van der sluys veer a, van ooteghem na. Dig Liver Dis. 2010 Jul;42(7):496-502. doi: 10.1016/j.dld.2009.10.006. Epub 2009 Dec 16. Dig Liver Dis. 2010. PMID: 20018575 Clinical Trial.

3

Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.

Van Vlerken LG, Van Soest H, Janssen MP, Boland GJ, Drenth JP, Burger DM, Siersema PD, Van Erpecum KJ. Van Vlerken LG, et al. Among authors: van soest h, van erpecum kj. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1308-15. doi: 10.1097/MEG.0b013e32833e784d. Eur J Gastroenterol Hepatol. 2010. PMID: 20729740 Clinical Trial.

4

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome.

van Vlerken LG, de Kanter CT, Boland GJ, van Loon AM, van Soest H, Koek GH, Drenth JP, Siersema PD, van Erpecum KJ, Burger DM. van Vlerken LG, et al. Among authors: van soest h. Ther Drug Monit. 2013 Aug;35(4):546-51. doi: 10.1097/FTD.0b013e31828a9fbf. Ther Drug Monit. 2013. PMID: 23851908 Clinical Trial.

5

Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients.

van Vlerken LG, Huisman EJ, van Soest H, Boland GJ, Drenth JP, Siersema PD, Burger DM, van Erpecum KJ. van Vlerken LG, et al. Among authors: van soest h, van erpecum kj. J Viral Hepat. 2012 Jan;19(1):39-46. doi: 10.1111/j.1365-2893.2010.01399.x. Epub 2010 Nov 29. J Viral Hepat. 2012. PMID: 21114586

6

Hepatitis C: changing genotype distribution with important implications for patient management.

van Soest H, Boland GJ, van Erpecum KJ. van Soest H, et al. Among authors: van erpecum kj. Neth J Med. 2006 Apr;64(4):96-9. Neth J Med. 2006. PMID: 16609154 Free article. Review.

7

Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era.

Berden FA, Kievit W, Baak LC, Bakker CM, Beuers U, Boucher CA, Brouwer JT, Burger DM, van Erpecum KJ, van Hoek B, Hoepelman AI, Honkoop P, Kerbert-Dreteler MJ, de Knegt RJ, Koek GH, van Nieuwkerk CM, van Soest H, Tan AC, Vrolijk JM, Drenth JP. Berden FA, et al. Among authors: van soest h. Neth J Med. 2014 Oct;72(8):388-400. Neth J Med. 2014. PMID: 25387551 Free article. Review.

8

Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination.

Isfordink CJ, van Dijk M, Brakenhoff SM, Kracht PAM, Arends JE, de Knegt RJ, van der Valk M, Drenth JPH; CELINE Study Group. Isfordink CJ, et al. Eur J Intern Med. 2022 Jul;101:93-97. doi: 10.1016/j.ejim.2022.04.024. Epub 2022 May 5. Eur J Intern Med. 2022. PMID: 35527178 Free article.

9

Clinical impact of five large-scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands.

Coenen S, van Meer S, Vrolijk JM, Richter C, van Erpecum KJ, Mostert MC, Veldhuijzen IK, Reijnders JG, van Soest H, Dirksen K, Drenth JP, Koene RP, Bosschart M, Friederich P, Ter Borg MJ, Daemen RH, Arends JE, Verhagen MA, Schout C, Spanier BW. Coenen S, et al. Among authors: van soest h. Liver Int. 2016 Oct;36(10):1425-32. doi: 10.1111/liv.13125. Epub 2016 May 2. Liver Int. 2016. PMID: 27001619

10

Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: a randomized controlled trial.

Huisman EJ, van Hoek B, van Soest H, van Nieuwkerk KM, Arends JE, Siersema PD, van Erpecum KJ. Huisman EJ, et al. Among authors: van soest h, van nieuwkerk km, van hoek b, van erpecum kj. J Hepatol. 2012 Nov;57(5):1069-75. doi: 10.1016/j.jhep.2012.06.029. Epub 2012 Jul 1. J Hepatol. 2012. PMID: 22760010 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page